BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24957886)

  • 1. A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women.
    Lacombe J; Mangé A; Bougnoux AC; Prassas I; Solassol J
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1834-42. PubMed ID: 24957886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
    Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
    Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
    Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in breast cancer: their use as an aid to early diagnosis.
    Chapman C; Murray A; Chakrabarti J; Thorpe A; Woolston C; Sahin U; Barnes A; Robertson J
    Ann Oncol; 2007 May; 18(5):868-73. PubMed ID: 17347129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer.
    Mangé A; Lacombe J; Bascoul-Mollevi C; Jarlier M; Lamy PJ; Rouanet P; Maudelonde T; Solassol J
    Clin Cancer Res; 2012 Apr; 18(7):1992-2000. PubMed ID: 22322670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum autoantibodies profiling and early-stage cancer detection].
    Desmetz C; Lacombe J; Mange A; Maudelonde T; Solassol J
    Med Sci (Paris); 2011; 27(6-7):633-8. PubMed ID: 21718648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study.
    Brem RF; Fishman M; Rapelyea JA
    Acad Radiol; 2007 Aug; 14(8):945-50. PubMed ID: 17659240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MRI outstands mammogram in sensitivity of breast ductal carcinoma in situ:an analysis of 122 cases].
    Yu QX; Chen XS; Wu JY; Han BS; He JR; Zhu L; Chen WG; Li YF; Tan L; Chai WM; Wang DB; Fei XC; Yuan F; Jin XL; Shen KW; Li HW
    Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):26-9. PubMed ID: 23578423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
    Koh VC; Lim JC; Thike AA; Cheok PY; Thu MM; Tan VK; Tan BK; Ong KW; Ho GH; Tan WJ; Tan Y; Salahuddin AS; Busmanis I; Chong AP; Iqbal J; Thilagaratnam S; Wong JS; Tan PH
    Breast Cancer Res Treat; 2015 Jul; 152(2):293-304. PubMed ID: 26077641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.
    Kuhl CK; Schrading S; Bieling HB; Wardelmann E; Leutner CC; Koenig R; Kuhn W; Schild HH
    Lancet; 2007 Aug; 370(9586):485-92. PubMed ID: 17693177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact of USPSTF recommendations on early diagnosis of breast cancer.
    Aragon R; Morgan J; Wong JH; Lum S
    Ann Surg Oncol; 2011 Oct; 18(11):3137-42. PubMed ID: 21947591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent.
    Santamaría G; Velasco M; Farrús B; Zanón G; Fernández PL
    Breast; 2008 Apr; 17(2):186-94. PubMed ID: 17964786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening.
    Trentham-Dietz A; Ergun MA; Alagoz O; Stout NK; Gangnon RE; Hampton JM; Dittus K; James TA; Vacek PM; Herschorn SD; Burnside ES; Tosteson ANA; Weaver DL; Sprague BL
    Breast Cancer Res Treat; 2018 Feb; 168(1):229-239. PubMed ID: 29185118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of ductal carcinoma in situ.
    Newstead GM
    Magn Reson Imaging Clin N Am; 2010 May; 18(2):225-40, viii. PubMed ID: 20494308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast.
    de Roos MA; van der Vegt B; de Vries J; Wesseling J; de Bock GH
    Ann Surg Oncol; 2007 Jul; 14(7):2097-104. PubMed ID: 17453296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
    Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
    Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast scintigraphy with breast-specific γ-camera in the detection of ductal carcinoma in situ: a correlation with mammography and histologic subtype.
    Spanu A; Sanna D; Chessa F; Cottu P; Manca A; Madeddu G
    J Nucl Med; 2012 Oct; 53(10):1528-33. PubMed ID: 22911882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy.
    Catteau X; Simon P; Noël JC
    Pathol Res Pract; 2012 Apr; 208(4):217-20. PubMed ID: 22445178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging.
    Menell JH; Morris EA; Dershaw DD; Abramson AF; Brogi E; Liberman L
    Breast J; 2005; 11(6):382-90. PubMed ID: 16297080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.